Opening the book…
Platelets are unique cellular components in the blood, playing an essential role in preventing excessive bleeding when blood vessels are damaged. Their dynamic nature and complex internal structure enable them to react swiftly and effectively to preserve the integrity of the circulatory system. Unlike typical cells, platelets are small cytoplasmic fragments with diameters ranging from 2 to 4 µm. These critical components are central to maintaining hemostasis, the process that halts bleeding by forming clots at sites of vascular injury.
Platelets have a relatively short lifespan, circulating in the blood for an average of 8 to 12 days before being removed by macrophages in organs such as the spleen, liver, and bone marrow. About one-third of the body's platelets are sequestered in the spleen, acting as a reserve. This reservoir ensures that platelets can be rapidly released when needed for clot formation and blood vessel repair, particularly during times of injury or high demand.
Thrombopoiesis is the process of the formation of platelets, which begins with HSCs in the bone marrow. HSCs differentiate into myeloid stem cells, which are progenitors for several blood cell lines, including the one responsible for platelet formation. From the myeloid stem cells, the next step in platelet production involves differentiation into a more specialized precursor cell called a megakaryoblast. The megakaryoblast is an immature, early-stage cell that will eventually give rise to megakaryocytes. Megakaryocytes grow to an enormous size through a process called endomitosis, where their DNA replicates multiple times without cell division, leading to a large, lobulated nucleus. This prepares the megakaryocyte for the final stages of platelet production. The mature megakaryocyte then extends long, branching cytoplasmic extensions called proplatelets into the blood vessels within the bone marrow. These proplatelets gradually fragment at their ends, releasing thousands of platelets into the bloodstream (Figure 10). Throughout this process, thrombopoietin, produced primarily by the liver, plays a key role in regulating megakaryocyte and platelet production, ensuring that platelet levels remain balanced to support proper hemostasis.6

Figure 10 | Thrombopoiesis | 5 This figure depicts the process of platelet formation, known as thrombopoiesis, from hematopoietic stem cells in the bone marrow. The hemocytoblast, a multipotent stem cell, gives rise to various blood cell types, including the myeloid stem cell, which serves as a progenitor for multiple blood cell lineages, including platelets. The megakaryoblast, derived from the myeloid stem cell, matures into a megakaryocyte—a large, multinucleated cell that fragments into small platelet units. Thrombopoietin, a regulatory hormone, plays a crucial role in stimulating platelet production throughout this differentiation process.
Platelets contain secretory vesicles filled with various bioactive molecules, including enzymes, hormones, and signaling molecules. They also possess delta (dense) granules, which are rich in ADP (a key molecule in platelet activation and aggregation), ATP, calcium ions (referred to as factor IV), serotonin (which activates nearby platelets), histamine, and epinephrine. Additionally, alpha granules carry essential components such as von Willebrand factor (vWF), fibrinogen, fibronectin, platelet factor-4, and platelet derived growth factor (PDGF), all of which are critical for repairing damaged blood vessel walls and contributing to the clotting process. Platelets also contain contractile proteins like actin and myosin, which play an important role in platelet plug formation by facilitating contraction during clot formation. Furthermore, platelets secrete prostaglandins, including thromboxane A₂ (TXA₂), a molecule that attracts and activates platelets. TXA₂ also indirectly promotes coagulation by encouraging the synthesis of thrombin, an enzyme that converts fibrinogen to fibrin, and by supporting the action of procoagulants, such as factor XIII, which stabilizes clots by cross-linking fibrin. Platelets also release anticoagulants and fibrinolytics, maintaining a balance in the clotting process.14
This page titled 8.10: Platelets was last modified on Wed, 19 Mar 2025 23:18:56 GMT and is shared under a CC BY-NC-SA 4.0 license and was authored, remixed, and/or curated by Chaya Gopalan (Consortium of Academic and Research Libraries in Illinois (CARLI)) .
The book could not be loaded just now.